FLQS - ETF AI Analysis
Top Page
Franklin LibertyQ U.S. Small Cap Equity ETF (FLQS)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and in recent months, showing positive momentum for investors.
Well-Diversified Across Sectors
Holdings are spread across many industries like technology, consumer, industrials, financials, and health care, which helps reduce the impact of weakness in any single sector.
Multiple Strong Top Holdings
Several of the largest positions, such as Alkermes, Esco Technologies, Moog, and Protagonist Therapeutics, have shown strong performance, supporting the fund’s overall results.
Negative Factors
Higher Expense Ratio for a Passive ETF
The fund’s fee is moderate but not especially low for an ETF, which slightly reduces the net return investors keep over time.
Small-Cap Company Risk
Because the ETF focuses on smaller U.S. companies, it can be more volatile and sensitive to economic slowdowns than funds holding larger, more established firms.
Heavy U.S.-Only Exposure
With almost all assets in U.S. stocks, the fund offers little geographic diversification and is highly tied to the health of the U.S. market.
FLQS vs. SPDR S&P 500 ETF (SPY)
AUM52.60M
RegionNorth America
Expense Ratio0.35%
Beta0.84
IssuerFranklin
Inception DateApr 26, 2017
Dividend Yield1.33%
Asset ClassEquity
Index TrackedLibertyQ US Small Cap Equity
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,296
30 Day Avg. Volume3,501
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
55.52Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering491
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FLQS Summary
Franklin LibertyQ U.S. Small Cap Equity ETF (FLQS) is a fund that tracks the LibertyQ US Small Cap Equity index, focusing on smaller U.S. companies across many sectors like technology, industrials, and health care. It holds a wide mix of stocks, including names like Alkermes and Moog, giving investors broad exposure to fast-growing smaller businesses that may have more room to expand than large, established firms. Someone might invest in FLQS for growth potential and diversification beyond big-company stocks. A key risk is that small-cap shares can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?The Franklin LibertyQ U.S. Small Cap Equity ETF (FLQS) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it uses a smart beta approach, actively selecting stocks based on factors like quality, value, and momentum rather than simply tracking an index.
What would affect this ETF?The Franklin LibertyQ U.S. Small Cap Equity ETF (FLQS) could benefit from economic growth and innovation in the U.S., particularly in sectors like technology and consumer cyclical, which are heavily represented in its holdings. However, rising interest rates or economic slowdowns may negatively impact small-cap stocks, as these companies often rely on borrowing and are more sensitive to market volatility. Additionally, sector-specific challenges, such as regulatory changes in healthcare or financials, could pose risks to the ETF's performance.
FLQS Top 10 Holdings
FLQS leans into U.S. small caps with a broad sector mix, but a few names are doing most of the heavy lifting. Health care plays like Alkermes and Protagonist Therapeutics have been rising, giving the fund a growth-oriented spark, while CareTrust REIT adds steady real estate income with a solid uptrend. On the industrial side, Moog and Esco Technologies have cooled recently, acting as mild brakes after earlier strength. Financials such as Essent Group and Selective Insurance are more mixed, keeping overall performance balanced rather than explosive.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alkermes | 1.06% | $558.55K | $8.22B | 85.96% | 80 Outperform | |
| Moog | 1.00% | $523.75K | $12.39B | 101.89% | 73 Outperform | |
| Esco Technologies | 0.99% | $521.10K | $8.17B | 64.15% | 70 Neutral | |
| Essent Group | 0.98% | $512.89K | $6.08B | 17.21% | 73 Outperform | |
| CareTrust REIT | 0.91% | $480.42K | $9.91B | 25.29% | 80 Outperform | |
| InterDigital | 0.88% | $461.06K | $7.87B | 14.34% | 76 Outperform | |
| Protagonist Therapeutics | 0.87% | $458.35K | $8.79B | 145.74% | 68 Neutral | |
| Compass | 0.87% | $457.72K | $8.51B | 38.23% | 61 Neutral | |
| FirstCash | 0.86% | $452.82K | $8.85B | 55.36% | 74 Outperform | |
| Enova International | 0.85% | $445.26K | $6.33B | 152.02% | 71 Outperform |
FLQS Technical Analysis
Positive
―
Price Trends
47.85
Positive
46.07
Positive
44.79
Positive
Market Momentum
0.48
Positive
63.21
Neutral
71.05
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLQS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 49.30, equal to the 50-day MA of 47.85, and equal to the 200-day MA of 44.79, indicating a bullish trend. The MACD of 0.48 indicates Positive momentum. The RSI at 63.21 is Neutral, neither overbought nor oversold. The STOCH value of 71.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLQS.
FLQS Peer Comparison
Comparison Results
Performance Comparison
FLQS
Franklin LibertyQ U.S. Small Cap Equity ETF
50.70
10.07
24.78%
BKSE
BNY Mellon US Small Cap Core Equity ETF
―
―
―
STXK
Strive 2000 ETF
―
―
―
AIMS
Acuitas Small Cap Active ETF
―
―
―
RUSC
US Small Cap Equity Active ETF
―
―
―
SYZ
Lazard US Systematic Small Cap Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents